Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that followed a six-month decline in the stock price.

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

Doctors have an overwhelming amount of individual patient data and medical research at their disposal to make diagnoses and ...

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things ...

The evolution of AI, more limited-time product offerings and GLP-1 use for weight loss are among the issues expected to play ...

The TacticID®-1064 ST is a 1064 nm handheld Raman device developed for law enforcement, first responders, and customs and ...

Next Generation Computing Market size is expected to reach USD 738.2 billion by 2033, projected at a CAGR of 18.5% during ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

In this edition of InnovationRx, medical debts will be erased from credit histories, this farm is doubling down on raw milk ...

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the twelfth annual Drugs to Watch™ report, a trusted guide to the therapies poised to ...

That’s why smart ring maker Movano wants to make one thing abundantly clear about its new chatbot, EvieAI: this one has been ...

CORSAIR® is proud to announce , during the 2025 CES in Las Vegas, that the latest CORSAIR and ORIGIN PC systems, powered by NVIDIA GeForce RTXtm 50 Series GPUs, are fully equipped to support NVIDIA ...